Drug Search Results

Etifoxine

Alternative Names: etifoxine
Latest Update: 2024-07-26
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: BZD Activator

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Indications: None

Known Adverse Events: None

Company: Biocodex
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Etifoxine

Countries in Clinic:

Active Clinical Trial Count: 1

Highest Development Phases

Phase 2: Bipolar Disorder

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success
2021-006773-38	P2	Active, not recruiting	Bipolar Disorder	2025-02-23

Recent News Events

Date	Type	Title
04/22/2024	PubMed	The translocator protein 18kDa ligand etifoxine in the treatment of depressive disorders-a double-blind, randomized, placebo-controlled proof-of-concept study.
02/06/2024	PubMed	Exploring the Roles of Vitamins C and D and Etifoxine in Combination with Citalopram in Depression/Anxiety Model: A Focus on ICAM-1, SIRT1 and Nitric Oxide.
11/14/2023	PubMed	Short-term effects of etifoxine on human gut microbiome in healthy men.
04/28/2023	News Article	atai Life Sciences Presents Pharmacodynamic Data on GRX-917 in a Late Breaking Poster Presentation at the 2023 SOBP Annual Meeting
03/06/2023	News Article	atai Life Sciences Announces Key Clinical Pipeline and Corporate Updates
01/09/2023	News Article	atai Life Sciences Company GABA Therapeutics Announces Positive Final Results from Phase 1 Single and Multiple Ascending Dose Trial of GRX-917
10/20/2022	News Article	atai Life Sciences Announces R&D Day Agenda

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions